PD IIS portal
Technologist with IIR

Investigator-Initiated Study

In Precision Diagnosis, we create smart connected systems, upgrade workflows, and generate insights from integrated diagnostics, leading to a clear care pathway and aiming at predictable outcomes for patients.

We are dedicated to supporting Investigator-Initiated Study. In pursuit of excellence, we partner with physicians and institutions worldwide to discover how we can combine the power of imaging, pathology, genomics and longitudinal data with insights from artificial intelligence to drive the right care in the right sequence at the right time.

Investigator-Initiated Study (IIS) Application Submission & Review Process

 

Thank you for your interest in submitting an IIS application. Below are simple steps for applying: 

 

Step 1: Complete and submit IIS application.

 

Step 2: The following documents are required for submission. Please provide those in a PDF format:

 

  • Letter from Institution and/or Principal Investigator (PI) requesting funding and/or additional support for their proposed clinical research study
  • Draft protocol or clinical research study synopsis
  • Current CV signed and dated (Note: All sensitive information i.e., DOB, Social Security Number should be removed prior to submission by the applicant.)
  • Detailed budget estimate

 

Once submitted, the IIS application is reviewed for completeness.

 

The IIS request will be reviewed against a specific qualifications list (please see the next tab) to ensure its scientific merit as well as alignment with our strategy and available budget. The IIS application will also go through legal and regulatory review.

 

The applicant will be contacted directly once a Review Committee decision is made.

Questions?

 

If you still have questions after reviewing the content on this site, please contact us at IISStudy.PD@philips.com.

What's trending

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.